期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性缺血性脑卒中炎性指标与循环内皮祖细胞的关系 被引量：1

Correlation between Endothelial Progenitor Cells and Inflammatory Factors in Patients with Acute Ischemic Stroke
下载PDF
导出
摘要 目的:探讨急性缺血性脑卒中患者血浆白介素-6(IL-6)、超敏C反应蛋白(hsCRP)水平与循环内皮祖细胞(EPCs)的关系。方法:选择2008年9月至2010年6月在我科经头颅CT证实诊断的急性缺血性脑卒中患者56例为研究组,以同期门诊健康体检者30例为对照组。检测两组就诊时IL-6、hsCRP及循环EPCs水平。结果:研究组血浆IL-6、hsCRP及循环EPCs水平均明显高于对照组,P<0.05;研究组患者IL-6、hsCRP与循环EPCs存在正相关,其相关系数分别为(r=0.367,P=0.030)及(r=0.429,P=0.016)。结论:在急性缺血性脑卒中患者中,在炎症损伤反应水平升高的同时,循环EPCs可能作为一种保护机制,其水平亦相应升高。 Objective： To investigate the relationship between endothelial progenitor cells and inflammatory factors （IL-6 and hsCRP） in patients with acute isehemic stroke. Methods： 56 patients with acute ischemic stroke diagnosed by computer tomography as research group and 30 health persons as control group were observed from Sep. 2008 to Jun.2010. The levels of IL-6, hsCRP and circulating EPCs were examined in the both group. Results： The levels of IL-6, hsCRP and circulating EPCs were significantly increased in research group than those in the control group,P〈0.05. There were positive correlation between IL-6, hsCRP and circulating EPCs, the correlation coefficient were r=0.367（P=0.030） and r= 0.429（P=0.016） respectively. Conclusion： Circulating EPCs might be an auto-protect mechanism in patients with acute ischemic stroke. The levels of circulating EPCs significantly increased as well as the levels of IL-6 and hsCRP.
作者 钟立新 刘志强 韩明
机构地区 广东省番禺区何贤纪念医院急诊科
出处 《岭南急诊医学杂志》 2011年第1期25-26,共2页 Lingnan Journal of Emergency Medicine
关键词 急性缺血性脑卒中 内皮祖细胞 白介素-6 超敏C反应蛋白 acute ischemic stroke endothelial progenitor cell IL-6 hsCRP
分类号 R743.3 [医药卫生—神经病学与精神病学]
  • 引文网络
  • 相关文献

参考文献5

  • 1李艳 ,黄从新 .重要炎性因子在冠心病病理过程中的作用[J].微循环学杂志,2004,14(1):47-49. 被引量：16
  • 2Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med, 2002,347 ( 3 ) : 185.
  • 3Rabelink TJ, De Boer HC, De Koning EJP, et al. Endothelial Progenitor Cells:More Than an Inflammatory Response? Arterioscler Thromb Vasc Biol, 2004,24 (5) : 834.
  • 4li M, Nishimura H, Iwakura A, et al. Endothelial Progenitor Cells Are Rapidly Recruited to Myoeardium and Mediate Protective Effect of Isehemic Preconditioning via "Imported" Nitric Oxide Synthase Activity. Circulation, 2005,111 (9) : 1114.
  • 5Shintani S, Murohara T, lkeda H, et al. Mobilization of endothelial progenitor ceils in patients with acute myocardial infarction. Circulation, 2001,103 ( 23 ) : 2776.

二级参考文献12

  • 1[1]Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340:115～126.
  • 2[2]Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J AM Coll Cardiol, 1998, 31:1 217～1 225.
  • 3[3]Schreyer SA, Vick CM,LeBoeuf RC. Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice. J Biol Chem, 2002, 277:12 364～12 368.
  • 4[4]Libby P, Warner SJ, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest,1998, 81:487～498.
  • 5[5]Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1receptor antagonist gene polymorphism in patients treated with coronary stenting. JACC, 2000, 36:2 168～2 173.
  • 6[6]Dewberry R, Holden H, Crossman D, et al. Interleukin-1 receptor antagonist expression in human endothelial cell and atherosclerosis. Arterioscler Thromb Vasc Biol, 2000, 20:2 394～2 400.
  • 7[7]Galea J, Armstrong JA, Gadsdon PA, et al. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol, 1996, 16:1 000～1 006.
  • 8[8]Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects-associations with obesity, insulin resistance and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Art Thromb Vasc Biol,1999,19:972～978.
  • 9[9]Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity,1997,6:1–20.
  • 10[10]Davies MJ. The composition of coronary artery plaques. New Engl J med, 1997, 336:1 312～1 314.

共引文献15

同被引文献11

  • 1周伟君,朱鼎良,李燕,陆一鸣,高平进.循环内皮祖细胞与急性脑卒中及脑血管危险因素的相关研究[J].中华老年心脑血管病杂志,2006,8(8):510-512. 被引量：7
  • 2KochanekKI), Xu J, MurphySl., et al. National vital statis- tics rcports~J]. Nalional Vital Statistics Reports, 2011 ~ 59 ( 4 ) : 1.
  • 3Asahara T, Murohara "1", Sullivan A, el al. Isolation of puta- tive progenitor endothelial cells for angiogenesisEJ].Science, 1997, 275:!/64 967.
  • 4Urbich (', Endothelial progenitor cells~ Characterization and rule in vascular biology~J~.Circulaticm Research, 2004,95: 343-353.
  • 5Miller-Kasprzak E, Jagodzifiski I~P. Endothelial progenitor ceils as ~l new agent contributing to vascular repairLJ~. Archivum Immunologi~eet Therapiae Experimentalis. 2007,55 .. 217-259.
  • 6Zampetaki A, Kirton JP,Xu Q. Vascular repair by endothelialprogenitor cells[J]. Cardiovasc Res, 2008,78 ~ 413-421.
  • 7Tang T,LiuXJ,Zhang ZQ, et al. Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats[J]. Brain Research, 2007, 1 175: 134-142.
  • 8Dzau VJ, Gnecchi M, Pachori AS, et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases[J]. Hypertension, 2005,46 ~ 7-18.
  • 9Murasawa S, Asahara T. Review~ Cardiogenic potential of en- dothelial progenitor cells[J]. Therapeutic Advances in Cardio- vascular Disease, 2008,2 ~ 341-348.
  • 10Carmeliet P, Jain RK. Molecular mechanisms and clinical appli-cations of angiogenesisEJ~. Nature, 2011,473 ( 7347) : 298-307.

引证文献1

二级引证文献7

岭南急诊医学杂志
2011年 第1期

相关作者

相关机构

相关主题

;
使用帮助 返回顶部